亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis

医学 内科学 肿瘤科 结直肠癌 危险系数 荟萃分析 子群分析 阶段(地层学) 化疗 循环肿瘤DNA 佐剂 微小残留病 癌症 生物标志物 置信区间 化学 白血病 古生物学 生物 生物化学
作者
Anusha Chidharla,Eliot Rapoport,Kriti Agarwal,Samragnyi Madala,Brenda Linares,Weijing Sun,Sakti Chakrabarti,Anup Kasi
出处
期刊:International Journal of Molecular Sciences [Multidisciplinary Digital Publishing Institute]
卷期号:24 (12): 10230-10230 被引量:20
标识
DOI:10.3390/ijms241210230
摘要

Emerging data have suggested that circulating tumor DNA (ctDNA) can be a reliable biomarker for minimal residual disease (MRD) in CRC patients. Recent studies have shown that the ability to detect MRD using ctDNA assay after curative-intent surgery will change how to assess the recurrence risk and patient selection for adjuvant chemotherapy. We performed a meta-analysis of post-operative ctDNA in stage I–IV (oligometastatic) CRC patients after curative-intent resection. We included 23 studies representing 3568 patients with evaluable ctDNA in CRC patient post-curative-intent surgery. Data were extracted from each study to perform a meta-analysis using RevMan 5.4. software. Subsequent subgroup analysis was performed for stages I–III and oligometastatic stage IV CRC patients. Results showed that the pooled hazard ratio (HR) for recurrence-free survival (RFS) in post-surgical ctDNA-positive versus -negative patients in all stages was 7.27 (95% CI 5.49–9.62), p < 0.00001. Subgroup analysis revealed pooled HRs of 8.14 (95% CI 5.60–11.82) and 4.83 (95% CI 3.64–6.39) for stages I–III and IV CRC, respectively. The pooled HR for RFS in post-adjuvant chemotherapy ctDNA-positive versus -negative patients in all stages was 10.59 (95% CI 5.59–20.06), p < 0.00001. Circulating tumor DNA (ctDNA) analysis has revolutionized non-invasive cancer diagnostics and monitoring, with two primary forms of analysis emerging: tumor-informed techniques and tumor-agnostic or tumor-naive techniques. Tumor-informed methods involve the initial identification of somatic mutations in tumor tissue, followed by the targeted sequencing of plasma DNA using a personalized assay. In contrast, the tumor-agnostic approach performs ctDNA analysis without prior knowledge of the patient’s tumor tissue molecular profile. This review highlights the distinctive features and implications of each approach. Tumor-informed techniques enable the precise monitoring of known tumor-specific mutations, leveraging the sensitivity and specificity of ctDNA detection. Conversely, the tumor-agnostic approach allows for a broader genetic and epigenetic analysis, potentially revealing novel alterations and enhancing our understanding of tumor heterogeneity. Both approaches have significant implications for personalized medicine and improved patient outcomes in the field of oncology. The subgroup analysis based on the ctDNA method showed pooled HRs of 8.66 (95% CI 6.38–11.75) and 3.76 (95% CI 2.58–5.48) for tumor-informed and tumor-agnostic, respectively. Our analysis emphasizes that post-operative ctDNA is a strong prognostic marker of RFS. Based on our results, ctDNA can be a significant and independent predictor of RFS. This real-time assessment of treatment benefits using ctDNA can be used as a surrogate endpoint for the development of novel drugs in the adjuvant setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jennica发布了新的文献求助30
2秒前
yc关闭了yc的文献求助
2秒前
6秒前
漂亮的新梅完成签到,获得积分10
7秒前
所所的应助被羊羊吃芋圆采纳,获得10
10秒前
whc发布了新的文献求助10
11秒前
21秒前
27秒前
辛勤诗兰完成签到,获得积分10
34秒前
羊羊吃芋圆完成签到,获得积分10
40秒前
情怀的应助被Prof.Z采纳,获得10
43秒前
caicai完成签到,获得积分20
49秒前
踏实的盼柳的应助被朝朝采纳,获得10
56秒前
Jasper的应助被科研通管家采纳,获得10
1分钟前
1分钟前
hhz发布了新的文献求助10
1分钟前
科研通AI6.3的应助被skyboyxiaobobo采纳,获得10
1分钟前
幽森之魅完成签到,获得积分10
1分钟前
大模型的应助被whc采纳,获得10
1分钟前
优秀笑柳完成签到,获得积分10
1分钟前
任性星星完成签到 ,获得积分10
1分钟前
hhz完成签到,获得积分10
1分钟前
Linden_bd完成签到 ,获得积分0
1分钟前
2分钟前
2分钟前
molihuakai的应助被amiee采纳,获得10
2分钟前
2分钟前
2分钟前
林一发布了新的文献求助10
2分钟前
余香的应助被icey采纳,获得10
2分钟前
icey对应助文件撤销了驳回
2分钟前
2分钟前
林一完成签到,获得积分10
2分钟前
amiee发布了新的文献求助10
2分钟前
3分钟前
3分钟前
3分钟前
儒雅的白曼完成签到,获得积分10
3分钟前
我是老大的应助被科研通管家采纳,获得10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190148
求助须知:如何正确求助?哪些是违规求助? 9577257
关于积分的说明 21852269
捐赠科研通 7788498
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2560043
邀请新用户注册赠送积分活动 2482880